Where to Buy Medical Cannabis for Glaucoma: A US Buying Guide
A US guide to buying medical cannabis for glaucoma: licensed dispensaries, delivery, telehealth cards, online retailers, dosing limits, and legal checks.
Medical cannabis for glaucoma treatment lowers eye pressure for a short window, but it does not treat the disease. Inhaled or oral THC can cut intraocular pressure by about 25 percent, and the effect fades in 3 to 4 hours. The American Academy of Ophthalmology and the American Glaucoma Society do not recommend cannabis as a glaucoma treatment.
how does cannabis help glaucoma
Yes, for a few hours. THC relaxes the ciliary body and changes the flow of fluid inside the eye.
A 1971 report in JAMA by Hepler and Frank was the first to describe pressure drops after cannabis smoking. Work in the 1970s and 1980s found the same brief window, and no trial since has turned that into a treatment.
The drop starts within an hour, peaks near 60 to 90 minutes, and ends by hour four. Repeat dosing builds tolerance, so a person who uses cannabis every 3 hours gets less pressure control with each round.
medical cannabis for glaucoma treatment
Glaucoma harms the optic nerve over years, not hours. Treatment has to hold pressure down around the clock, every day, for the rest of a patient's life.
To copy that with cannabis, a patient would need a dose every 3 hours, including overnight. The level of intoxication needed would leave most people unable to work, drive, or sleep through the night.
Standard glaucoma care aims at steady pressure control with tools tested in long-term trials.
Prostaglandin analogs such as latanoprost lower pressure 25 to 33 percent with one drop at bedtime. Beta blockers, alpha agonists, and carbonic anhydrase inhibitors are other common classes, often stacked for extra effect.
Selective laser trabeculoplasty (SLT) opens the drainage meshwork and can hold pressure for years. It is an in-office procedure that takes minutes.
Trabeculectomy, drainage implants, and minimally invasive glaucoma surgeries (MIGS) create new outflow paths when drops and laser fall short.
Each option is standardized, reviewed by the FDA, and measured against vision outcomes, not just pressure numbers.
Some research points that way. Small studies have found that CBD can raise intraocular pressure, the opposite of what a glaucoma patient needs.
CBD also ties up liver enzymes that clear other drugs, so it can change how blood thinners, seizure medicines, and other prescriptions behave in the body.
Labels on cannabis products sold online and in shops do not always match lab results, which makes dose control hard even when a product lists a set amount of THC or CBD. Buying from licensed, lab-tested brands narrows that gap.
State programs added glaucoma to qualifying condition lists after those 1970s studies made headlines. Clinical practice moved on. Most lists stayed the same.
In states that still include glaucoma, a doctor can certify a patient and a dispensary can sell the product. That card does not change what an ophthalmologist will do next, which is drops, laser, or surgery.
Rules differ by state, so check your own program for current terms before you pay for a certification visit.
Cannabis is not a substitute for glaucoma care, but some patients ask about it. Treat it as an add-on and tell your eye doctor.
No. Drops hold pressure for 24 hours with one dose a day. Cannabis holds it for 3 to 4 hours and builds tolerance with repeat use.
About 3 to 4 hours after smoking or oral use. The peak lands at 60 to 90 minutes.
No. CBD may raise eye pressure and it interacts with prescription drugs.
In some US states, yes. Check your state health department list, since qualifying conditions change.
Medical cannabis for glaucoma treatment can move the numbers on a pressure test for a few hours, and that is where the benefit ends. Glaucoma is a lifelong disease that needs steady pressure control, which cannabis cannot deliver at a safe dose. Stick with drops, laser, or surgery, and talk to your eye doctor before adding anything else.